Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion.
about
Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction?Myocardial reperfusion injury: looking beyond primary PCIHeart-resident CCR2+ macrophages promote neutrophil extravasation through TLR9/MyD88/CXCL5 signaling.Novel regulatory mechanism of cardiomyocyte contractility involving ICAM-1 and the cytoskeletonEnterocyte shedding and epithelial lining repair following ischemia of the human small intestine attenuate inflammationMechanisms and consequences of phagocyte adhesion to endothelium.Intensive insulin therapy protects the endothelium of critically ill patientsSialyl Lewisx-containing oligosaccharide attenuates myocardial reperfusion injury in cats.Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathwayInterleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo.Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8.Do neutrophils contribute to myocardial reperfusion injury?Differential effects of monoclonal antibody blockade of adhesion molecules on in vivo susceptibility to soft tissue infectionIn vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury.Acute inflammatory reaction after myocardial ischemic injury and reperfusion. Development and use of a neutrophil-specific antibody.Resveratrol pretreatment protects rat hearts from ischemia/reperfusion injury partly via a NALP3 inflammasome pathway.Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation.Cardioprotective actions of oligotide, a single stranded polydeoxyribonucleotide complex, in myocardial ischaemia and reperfusion injury.Effect of duration of ischaemia on reduction of myocardial infarct size by inhibition of neutrophil accumulation using an anti-CD18 monoclonal antibody.The Fifth Domain of Beta 2 Glycoprotein I Protects from Natural IgM Mediated Cardiac Ischaemia Reperfusion InjuryMechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion.Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement.Myocardial ischemia-reperfusion injury: a neglected therapeutic target.The immune system and cardiac repair.Targeting inflammatory pathways in myocardial infarction.Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation--a novel mechanism for the cardioprotective effects of PPAR agonists.Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation.P2Y2 receptor agonist with enhanced stability protects the heart from ischemic damage in vitro and in vivoMechanisms of muscle injury, repair, and regeneration.Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges.Leukocyte CD11a expression and granulocyte activation during experimental myocardial ischemia and long lasting reperfusion.Restoration of the cAMP second messenger pathway enhances cardiac preservation for transplantation in a heterotopic rat model.Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusionHypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice.Reperfusion injury as the mechanism of brain damage after perinatal asphyxia.Morphine postconditioning attenuates ICAM-1 expression on endothelial cells.Mechanisms of cell death in acute myocardial infarction: pathophysiological implications for treatmentReduction of Myocardial Infarct Size in the Rabbit by a Carbohydrate Analog of Sialyl Lewis(x).Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia.NO produced by endothelial NO synthase is a mediator of delayed preconditioning-induced endothelial protection.
P2860
Q24794238-652A84AE-40A5-48C4-8E74-43E9DC3535E9Q26991482-86651BFB-E375-4AE0-8823-A4E43DC5EC84Q27333707-87966CC9-A2EE-4614-9924-36BFD7DFEFA8Q28574740-D2B8A350-717B-4BFE-A0D0-361DA376C40DQ33503228-44A06128-D57D-4381-A328-275108700DC9Q33708657-4EC39482-189D-41BA-A7E8-49A99963FE13Q33905796-76502B74-BDDE-40A1-8770-70745F6E6002Q34132844-3D6FB4B4-31B4-47D9-B278-D0CFDFDBED9EQ34147762-B2CF2EB0-1E5F-46DD-8940-7A853E4266A0Q34193068-1F4A320A-EBB0-4824-8A5C-7A1487D36932Q34223846-F8241C3B-FEBB-4353-B384-31D7DAEDCD6AQ34814479-A53B18F5-4098-46FF-AE8E-98D4D736BB79Q35441466-C3689072-6420-4E31-BC6F-5B7F93C5B82CQ35610891-3018A17A-B070-4E27-9C80-5468FA71B6A3Q35774070-105895AB-222E-4C84-AA40-4BBAA5DC51E9Q35805767-FDCFE70F-4C38-4583-9176-7F146BC4278EQ35829716-FAB527F5-AC7F-41E0-8728-409048CF16BAQ35873945-394BFA4B-44CA-41AB-AE46-32928C4117AEQ35874470-80D7A1FC-7EE2-48F1-86C1-180D19A77476Q35974974-3CF44BC1-303D-499C-849F-8A6B09F214F9Q36086349-12A3382B-F8B4-407E-BA55-32B4BE61E1DCQ36366602-A69DB7A9-E7A8-4CAE-8EB5-4313C064B8A0Q36497176-F9BFC882-EE2C-4EC8-8756-D4B54F1E7DA7Q37096652-1752427C-3F8B-4F62-A3E8-5338F76FF3FCQ37100838-6C21CD1D-16B2-462B-B6F1-B200142CDCC2Q37291297-974A417A-8233-4792-A19A-0D91512DF817Q37350527-1E804935-5C6C-4C4C-98C4-DC37377436D5Q37468700-F633FA97-A5D0-42A3-8205-D6ABCBCC660AQ38111732-497708FF-7659-4339-97F6-D93670073ABBQ38560476-0514DE92-8953-4A17-9C70-DC678A33AD9FQ40170156-5FDFC8AB-6C8F-40D7-9828-CC31225DDBC9Q40306163-47CC776E-AB43-4C25-BC97-463FF5D3ADB8Q40343949-7721D42F-AABB-4E97-B433-D0745BB8D75FQ40431909-4A0A8EEF-7FEE-48F0-A5E7-8D04F764978EQ40896883-3E8A864C-5463-4C67-8980-1EF780EB5F67Q41892326-2A21F015-880D-495C-B70D-3E78DBFB91DBQ42332637-1356BB69-7120-47A9-A248-A6F7C3A501DBQ42619499-BA369D59-ACC8-47C1-A620-7D797625DB4CQ43610521-0F3AC697-3A49-4484-95EE-2A75123EB75CQ44274462-69A3E3A1-6A45-42B4-A76B-340F38D63867
P2860
Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion.
description
1991 nî lūn-bûn
@nan
1991 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Antibody to CD-18 exerts endot ...... dial ischemia and reperfusion.
@ast
Antibody to CD-18 exerts endot ...... dial ischemia and reperfusion.
@en
Antibody to CD-18 exerts endot ...... dial ischemia and reperfusion.
@nl
type
label
Antibody to CD-18 exerts endot ...... dial ischemia and reperfusion.
@ast
Antibody to CD-18 exerts endot ...... dial ischemia and reperfusion.
@en
Antibody to CD-18 exerts endot ...... dial ischemia and reperfusion.
@nl
prefLabel
Antibody to CD-18 exerts endot ...... dial ischemia and reperfusion.
@ast
Antibody to CD-18 exerts endot ...... dial ischemia and reperfusion.
@en
Antibody to CD-18 exerts endot ...... dial ischemia and reperfusion.
@nl
P2093
P2860
P356
P1476
Antibody to CD-18 exerts endot ...... dial ischemia and reperfusion.
@en
P2093
P2860
P304
P356
10.1172/JCI115427
P407
P577
1991-10-01T00:00:00Z